-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
-
The Role of Nurse Navigators in Lung Cancer: Advocates, Sounding Boards, and Care Coordinators for Patients
My primary goal as a nurse navigator is to provide patient-centered care while facilitating timely access to the right providers. Nurse navigators have the clinical expertise to individualize both their education and assistance to patients and their caregivers throughout the course of the patient’s disease. My priorities are to assess for barriers that will prevent…
-
Using Tumor Radiomic Features To Predict NSCLC Chemotherapy Response
IN REFERENCE TO: Khorrami M, Jain P, Bera K, et al. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features. Lung Cancer. 2019;135:1-9.
-
In Memorium: Tobacco-Control Innovator, Former President of Uruguay, Dr. Tabaré Vázquez Dies from Lung Cancer at 80
Former President of Uruguay and oncologist, Dr. Tabaré Vázquez, died at age 80 from lung cancer on December 6, 2020. He became the first Socialist leader of Uruguay during his first presidency (2005-2010). Dr. Vázquez implemented some of the most stringent tobacco control measures in the world, which serve as a model for other countries.…
-
Growing Importance and Changing Dynamics: Social Media’s Ever-Changing Role in Thoracic Oncology
Although some resist its gravitational pull, social media and especially Twitter are becoming an increasingly valuable tool in academic and community-based cancer care, with thoracic oncology helping set the pace for its growing presence. As its utility continues to grow, social media has been forging a stronger international community that is no longer limited by…
-
The Multitude of Options for First-Line Therapy for EGFR-Mutated Lung Cancer
Speaking as a medical oncologist who cares for patients with lung cancer, the present is filled with much hope. There has been a profusion of studies that report increasingly improved outcomes for patients with lung cancer, both in early and advanced stages. Specifically, for a patient with advanced lung cancer with an EGFR-sensitizing mutation, the…
-
A Lack of Standardization in Toxicity Reporting Leaves the Field Open to Misinformation
With many new lung cancer treatments approved through accelerated tracks based on early-phase (I/II) trial data, we have become increasingly aware of the lack of standards for disclosing toxicities when new therapies debut at professional conferences, which may be months to a few years before they are licensed. We collected toxicity data from all lung…
-
High Risk of Thromboembolic Events in Patients With NSCLC With ALK/ROS1 Fusions
The relationship between cancer and thromboembolic events as been widely studied since 1895. As we know, venous thromboembolism (VTE) is a well-recognized complication of malignancy, including pulmonary embolism (PE), deep-vein thrombosis (DVT), and migratory thrombophlebitis (Trousseau syndrome). It is reported that patients with cancer have a 4-fold greater risk to suffer from VTE than the…
-
Physician's Twitter Campaign Boosts UK Quit Smoking Efforts
More than 1 million smokers—and counting—have #QuitforCOVID.
-
Remotely Monitoring Patients With Cancer Has Applicability During COVID-19 Pandemic and Beyond
The pandemic underscores unmet needs in critical care management and presents an opportunity for learning from patients with cancer.
-
Decade in Review: Changes in Smoking Behaviors Are Altering the Clinical Picture of Lung Cancer
Lung cancer still holds the top position worldwide in terms of the number of new cases and deaths each year, which in 2018 reached 2.1 million and 1.8 million, respectively.1 Given that roughly 85% of all lung cancers can be traced to cigarette smoking, many countries have sought to rein in the morbidity and mortality of the disease by implementing public health initiatives and…